Stock Price Forecast

Jan. 26, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Aravive Inc chart...

About the Company

versartis, inc. (nasdaq: vsar) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. the company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. versartis’ mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. learn more at www.versartis.com.

CEO

Gail McIntyre

Exchange

NASDAQ

Website

https://aravive.com/

$60M

Total Revenue

40

Employees

$3M

Market Capitalization

-0.11

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ARAV News

Why Is Aravive Stock Sinking Today?

7mon ago, source: Hosted on MSN

Aravive Inc (NASDAQ: ARAV) shares plunged after the company's Phase 3 AXLerate-OC trial evaluating the safety and efficacy of batiraxcept in platinum-resistant ovarian cancer did not meet its ...

Aravive, Inc. (ARAV) Stock Historical Prices & Data - Yahoo Finance

1mon ago, source: Yahoo Finance

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

Rekha Hemrajani's Net Worth

24d ago, source: Benzinga.com

Inc., Jiya Acquisition Corp., and Aravive, Inc.. Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks ...

Nasdaq Jumps Over 100 Points; US Jobless Claims Fall To 187,000

2mon ago, source: Hosted on MSN

Celularity Inc. (NASDAQ: CELU) shares were also up, gaining 59% to $0.3013 after falling more than 5% on Wednesday. Aravive, Inc. (NASDAQ: ARAV) shares dropped 51% to $0.0541. Aravive intends to ...

Shahzad Malik's Net Worth

11d ago, source: Benzinga.com

Conatus Pharmaceuticals Inc, and Aravive, Inc.. Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and ...

Welcome to Inc.'s Directory of B2B Excellence

4mon ago, source: Inc

They all made it through Inc.'s proprietary vetting process, based in part on testimonials from other clients. As any entrepreneur knows, the right partnership can make all the difference.

STIHL Inc.

7mon ago, source: Forbes

This company has paid to receive expanded profile features. About STIHL Inc. Virginia-based STIHL Inc. is the U.S. affiliate for the global STIHL group and the manufacturer of the number one ...

Snap Inc Class A

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Block Inc.

5mon ago, source: Wall Street Journal

1 Day SQ -1.32% DJIA -0.49% S&P 500 -0.65% Technology -1.75% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum ...

Apple Inc.

20d ago, source: Wall Street Journal

1 Day AAPL 2.56% DJIA 0.30% S&P 500 1.05% Technology -1.75% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum ...

Aravive, Inc. (ARAV) stock historical prices & data – Yahoo Finance

1mon ago, source: Yahoo Finance

*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...